Erbilgin, Y. Et Al. 2013. Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance. 55th Annual Meeting of the American-Society-of-Hematology , (Louisiana, United States Of America).

Erbilgin, Y., Eskazan, A. E., NG, O. H., Salihoglu, A., Elverdi, T., Firtina, S., ... TATONYAN, S. C.(2013). Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance . 55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America

Erbilgin, Yücel Et Al. "Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance," 55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 2013

Erbilgin, Yücel Et Al. "Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance." 55th Annual Meeting of the American-Society-of-Hematology , Louisiana, United States Of America, 2013

Erbilgin, Y. Et Al. (2013) . "Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance." 55th Annual Meeting of the American-Society-of-Hematology , Louisiana, United States Of America.

@conferencepaper{conferencepaper, author={Yücel ERBİLGİN Et Al. }, title={Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance}, congress name={55th Annual Meeting of the American-Society-of-Hematology}, city={Louisiana}, country={United States Of America}, year={2013}}